-The Telegraph A physicians-led health group has expressed fears that the Centre is straying from plans to provide free essential medicines at public hospitals and to introduce Universal healthcare services through tax revenues. The non-government Jan Swasthya Abhiyan (JSA) has said the plans for free essential medicines and an expansion and strengthening of public health services in rural areas appear to be in jeopardy because of inadequate health budget allocations. In a letter...
More »SEARCH RESULT
Stuck record: Why Amartya Sen is wrong on food security again -R Jagannathan
-Firstpost.com It is becoming increasingly difficult to retain respect for Nobel laureate Amartya Sen. He seems to surface in the media every time the UPA government is about to legislate its pet follies, providing intellectual succour to mindless spending and corruption wrapped up in the package of anti-poverty schemes. Yesterday, Sen bobbed up just when the UPA - under siege for every known scam in India - tried to start discussions on...
More »Urban Health Mission to cover 7.75 crore people
-The Hindu The Union Cabinet on Wednesday approved the Rs. 22,507-crore National Urban Health Mission (NUHM) that seeks to address healthcare challenges in towns and cities with focus on urban poor. The Union Cabinet on Wednesday approved the Rs. 22,507-crore National Urban Health Mission (NUHM) that seeks to address healthcare challenges in towns and cities with focus on urban poor. The scheme will now be introduced as a sub-mission under the National...
More »Social Justice
KEY TRENDS • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8 • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...
More »SC’s Novartis judgement renews focus on accessible medicine
The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »